Novel micelle formulations to increase cutaneous bioavailability of azole antifungals
- 30 July 2011
- journal article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 153 (2), 126-132
- https://doi.org/10.1016/j.jconrel.2011.03.003
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Novel Cyclosporin A formulations using MPEG–hexyl-substituted polylactide micelles: A suitability studyEuropean Journal of Pharmaceutics and Biopharmaceutics, 2011
- Superficial mycoses in immunodepressed patients (AIDS)Clinics in Dermatology, 2010
- Epidemiology of superficial fungal infectionsClinics in Dermatology, 2010
- Superficial fungal infectionsMedicine, 2009
- Colloidal Drug Delivery Systems – Recent Advances With Polymeric MicellesChimia, 2008
- Developments in the epidemiolgy of invasive fungal infections – implications for the empiric and targeted antifungal therapyMycoses, 2008
- Novel polymeric micelles for hydrophobic drug delivery based on biodegradable poly(hexyl-substituted lactides)International Journal of Pharmaceutics, 2006
- Transdermal drug delivery: overcoming the skin’s barrier functionPharmaceutical Science & Technology Today, 2000
- Superficial fungal infections of the skin: Tinea corporis, tinea pedis, and Candida intertrigoPrimary Care Update for OB/GYNS, 1995
- Mode of action of anti-Candida drugs: Focus on terconazole and other ergosterol biosynthesis inhibitorsAmerican Journal of Obstetrics and Gynecology, 1991